Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elliott Levy"'
Autor:
Jung-Min Lee, Seth M. Steinberg, Janis M. Taube, Christina M. Annunziata, Stanley Lipkowitz, Marc R. Radke, Elliott Levy, Mohammad H. Bagheri, Erin Nichols, Andrew B. Nixon, James W. Hodge, Elizabeth M. Swisher, Yingmiao Liu, Jayakumar R. Nair, Ashley Cimino-Mathews, Michelle Padget, Alexandra Zimmer, Erika J. Lampert
Supplementary methods, tables, figures 1-5 with corresponding figure legends, and references
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d4e53e79f70b59e1d9a2637b68d09a
https://doi.org/10.1158/1078-0432.22479107.v1
https://doi.org/10.1158/1078-0432.22479107.v1
Autor:
Jung-Min Lee, Seth M. Steinberg, Janis M. Taube, Christina M. Annunziata, Stanley Lipkowitz, Marc R. Radke, Elliott Levy, Mohammad H. Bagheri, Erin Nichols, Andrew B. Nixon, James W. Hodge, Elizabeth M. Swisher, Yingmiao Liu, Jayakumar R. Nair, Ashley Cimino-Mathews, Michelle Padget, Alexandra Zimmer, Erika J. Lampert
Purpose:Preclinical studies suggest PARP inhibition (PARPi) induces immunostimulatory micromilieu in ovarian cancer thus complementing activity of immune checkpoint blockade. We conducted a phase II trial of PARPi olaparib and anti–PD-L1 durvalumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572309380d18f2e0fb8fb6a6ca8c8066
https://doi.org/10.1158/1078-0432.c.6530135
https://doi.org/10.1158/1078-0432.c.6530135
Publikováno v:
American Journal of Hypertension. 17:103-111
Background Recent reports suggest that existing antihypertensive agents may not have sufficient efficacy to control blood pressure (BP) in many patients. Omapatrilat, an agent under development, has been shown to have significantly greater antihypert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::416a3cd05c5ce70bf02570b53c804cc4
https://doi.org/10.1016/j.amjhyper.2003.09.014
https://doi.org/10.1016/j.amjhyper.2003.09.014
Autor:
John H. Alexander, Christopher B. Granger, Junyuan Wang, Lars Wallentin, Jack Lawrence, Robert M. Califf, Michael G. Hanna, Elliott Levy, Anthony P. Waclawski
Publikováno v:
American heart journal. 166(3)
Background In ARISTOTLE, apixaban resulted in a 21% reduction in stroke, a 31% reduction in major bleeding, and an 11% reduction in death. However, approval of apixaban was delayed to investigate a statement in the clinical study report that "7.3% of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fe28ac60ab64ba6b680aa712baaf14
https://pubmed.ncbi.nlm.nih.gov/24016507
https://pubmed.ncbi.nlm.nih.gov/24016507
Autor:
Thomas B. Casale, Harold J. Kim, Allen P. Kaplan, James Rusnak, John B. Kostis, Jonathan Corren, Elliott Levy
Publikováno v:
Archives of internal medicine. 165(14)
Background Angioedema is a rare but potentially serious adverse event of angiotensin-converting enzyme inhibitor therapy. However, no prospective, controlled studies have reported on its incidence and clinical characteristics. Methods We studied the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b420c6e7469bcb331c47d44c40a0fb9b
https://pubmed.ncbi.nlm.nih.gov/16043683
https://pubmed.ncbi.nlm.nih.gov/16043683
Autor:
Elliott Levy, Sherman Hayes
Publikováno v:
The Bottom Line. 7:32-34
We all spend time and money on staff development. It is the “new frontier” of the 1990s. William Edwards Deming of Total Quality Management fame speaks constantly to the need to have a highly motivated and trained work force. Library literature i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b95945db638636d0bf8cc63467f3066c
https://doi.org/10.1108/eb025403
https://doi.org/10.1108/eb025403
Autor:
Raisa Levin, Jerry Avorn, Elliott Levy, Robert J. Glynn, Rhonda L. Bohn, Wolfgang C. Winkelmayer, William F. Owen
Publikováno v:
Archives of Internal Medicine. 162:2002
For patients with chronic renal insufficiency, rates of referral to nephrologists are highly variable, and little is known about the effect of such consultation on clinical outcomes. We sought to determine whether early or frequent access to nephrolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47585eb07c49c951a6b0cbec60b97335
https://doi.org/10.1001/archinte.162.17.2002
https://doi.org/10.1001/archinte.162.17.2002